Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer

Biochemical and Biophysical Research Communications

Volumn 438, Issue 4, 2013, Pages 673-679

  Tan, Min ^a   Wu, Junjie ^b,c   Cai, Yong ^d  

^a TONGJI UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

DNA methyltransferases; MiR 29 family; Non small cell lung cancer; Wnt inhibitory factor 1; Wnt signaling

Indexed keywords

BETA CATENIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; UNCLASSIFIED DRUG; WNT INHIBITORY FACTOR 1 PROTEIN; WNT PROTEIN;

APOPTOSIS; ARTICLE; CANCER SURGERY; CANCER TISSUE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; POLYMERASE CHAIN REACTION; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

DNA METHYLTRANSFERASES; MIR-29 FAMILY; NON-SMALL-CELL LUNG CANCER; WNT INHIBITORY FACTOR-1; WNT SIGNALING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA, NON-SMALL-CELL LUNG; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; METHYLATION; MICRORNAS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; WNT SIGNALING PATHWAY;

EID: 84883274471     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.123     Document Type: Article

References (31)

1. Guo P., Huang Z.L., Yu P., Li K. Trends in cancer mortality in China: an update. Ann. Oncol. 2012, 23(10):2755-2762.
2. Polakis P. Wnt signaling and cancer. Genes Dev 2000, 14(15):1837-1851.
3. Uematsu K., He B., You L., Xu Z., McCormick F., et al. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003, 22(46):7218-7221.
4. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17(1):9-26.
5. Veeman M.T., Axelrod J.D., Moon R.T. A second canon: functions and mechanisms of beta-catenin-independent Wnt signaling. Dev. Cell 2003, 5(3):367-377.
6. Xu X., Sun P.L., Li J.Z., Jheon S., Lee C.T., et al. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery. J. Thorac. Oncol. 2011, 6(4):716-724. 10.1097/JTO.0b013e31820c5189.
7. Mazieres J., He B., You L., Xu Z., Lee A.Y., et al. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res. 2004, 64(14):4717-4720.
8. Jeltsch A. Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases. ChemBioChem 2002, 3(4):274-293.
9. Girault I., Tozlu S., Lidereau R., Bièche I. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin. Cancer Res. 2003, 9(12):4415-4422.
10. Saito Y., Kanai Y., Nakagawa T., Sakamoto M., Saito H., et al. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int. J. Cancer 2003, 105(4):527-532.
11. Kim H., Kwon Y.M., Kim J.S., Han J., Shim Y.M., et al. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Cancer 2006, 107(5):1042-1049.
12. Lin R.K., Hsu H.S., Chang J.W., Chen C.Y., Chen J.T., et al. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer 2007, 55(2):205-213.
13. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
14. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA 2007, 104(40):15805-15810.
15. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103(7):2257-2261.
16. Mott J.L., Kurita S., Cazanave S.C., Bronk S.F., Werneburg N.W., et al. Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J. Cell. Biochem. 2010, 110(5):1155-1164.
17. Desjobert C., Renalier M.H., Bergalet J., Dejean E., Joseph N., et al. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood 2011, 117(24):6627-6637.
18. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 1997, 111(6):1710-1717.
19. You L., He B., Xu Z., Uematsu K., Mazieres J., et al. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004, 23(36):6170-6174.
20. He B., You L., Uematsu K., Xu Z., Lee A.Y., et al. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 2004, 6(1):7-14.
21. Ugolini F., Charafe-Jauffret E., Bardou V.J., Geneix J., Adélaïde J., et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 2001, 20(41):5810-5817.
22. Suzuki H., Watkins D.N., Jair K.W., Schuebel K.E., Markowitz S.D., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 2004, 36(4):417-422.
23. Taniguchi H., Yamamoto H., Hirata T., Miyamoto N., Oki M., et al. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005, 24(53):7946-7952.
24. Deng Y., Yu B., Cheng Q., Jin J., You H., et al. Epigenetic silencing of WIF-1 in hepatocellular carcinomas. J. Cancer Res. Clin. Oncol. 2010, 136(8):1161-1167.
25. Suzuki M., Shigematsu H., Nakajima T., Kubo R., Motohashi S., et al. Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non-small cell lung cancer. Clin. Cancer Res. 2007, 13(20):6087-6092.
26. Cebrat M., Strzadala L., Kisielow P. Wnt inhibitory factor-1: a candidate for a new player in tumorigenesis of intestinal epithelial cells. Cancer Lett. 2004, 206(1):107-113.
27. Mott J.L., Kobayashi S., Bronk S.F., Gores G.J. Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26(42):6133-6140.
28. Garzon R., Heaphy C.E.A., Havelange V., Fabbri M., Volinia S., et al. MicroRNA 29b functions in acute myeloid leukemia. Blood 2009, 114(26):5331-5341.
29. Xiong Y., Fang J.H., Yun J.P., Yang J., Zhang Y., et al. Effects of MicroRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010, 51(3):836-845.
30. Park S.Y., Lee J.H., Ha M., Nam J.W., Kim V.N. MiR-29 miRNAs activate p53 by targeting p85[alpha] and CDC42. Nat. Struct. Mol. Biol. 2009, 16(1):23-29.
31. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 2008, 40(1):43-50.